Hepatitis B vaccine - Chiron
Alternative Names: HBV/MF59; Hepatitis B immunotherapy - ChironLatest Information Update: 17 Dec 2021
At a glance
- Originator Chiron Corporation
- Class Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 25 Oct 2002 Discontinued - Phase-II for Hepatitis B treatment in Asia (unspecified route)
- 25 Oct 2002 Discontinued - Phase-II for Hepatitis B treatment in USA (unspecified route)
- 22 Nov 2000 Phase-II clinical trials in Hepatitis B treatment in Asia (unspecified route)